TScan Therapeutics Announces Pricing of $140 Million Public Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. META
6. NVDA
7. DRI
8. ULS
9. CRL
10. VEON

Go back to TScan Therapeutics Announces Pricing of $140 Million Public Offering
Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) Delayed: 0.34 -0.01 (2.86%)
Previous Close $0.35    52 Week High $26.80 
Open $0.35    52 Week Low $23.00 
Day High $0.37    P/E N/A 
Day Low $0.33    EPS $0.00 
Volume 267,884